FDA advisory panel votes against vaccine booster for most Americans

An FDA advisory committee overwhelmingly rejected a third dose of Pfizer’s vaccine for most adults, but in an unexpected second vote authorized its use for those 65 and older and people at high risk of contracting severe Covid-19.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting